SM1 – UBS rates the stock as Buy

The first half earnings fell -58% because of a sharp reduction in high-margin infant formula volumes and associated manufacturing efficiencies with low off-season dryer utilisation.

Nevertheless, Synlait Milk is trading on a record discount to book value for a business with hard assets and proven world-class manufacturing capability, the broker asserts.

UBS lowers estimates by -94% for FY21 and -18% for FY22, reflecting a temporary increase in manufacturing unit costs and lower basic ingredient price premiums. Buy rating retained. Target is reduced to NZ$5.55 from NZ$5.75.

Sector: Food, Beverage & Tobacco.

 

Current Price is $3.12. Target price not assessed.

 

S32 – SOUTH32 LIMITED Macquarie rates the stock as Outperform –

The divestment of the South Africa Energy Coal business, which has been loss-making over the past three years, is set to be completed. Macquarie notes this is a key catalyst as the sale simplifies the business.

Meanwhile, earnings upgrade momentum has improved because of stronger silver, nickel and manganese prices. A spot price scenario generates earnings largely in line with forecasts and Macquarie retains an Outperform rating and $3.10 target.

Sector: Materials.

 

Target price is $3.10.Current Price is $2.84. Difference: $0.26 – (brackets indicate current price is over target). If S32 meets the Macquarie target it will return approximately 8% (excluding dividends, fees and charges – negative figures indicate an expected loss).

 

 

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →